Narrative review / 2011
Metabolic syndrome has a ~25% US prevalence, predicts diabetes and cardiovascular disease, and is linked to NASH.
Metabolic syndrome has emerged as a major public health concern with an estimated prevalence of approximately 25% in the United States. It centers around central obesity, hypertension, low high-density lipoproteins, and elevated triglycerides, with insulin resistance as the uniting factor, and predicts the development of diabetes and cardiovascular disease. Nonalcoholic fatty liver disease represents its hepatic component, which can progress to nonalcoholic steatohepatitis (NASH). Weight loss through diet or bariatric surgery and vitamin E have recently been demonstrated as effective treatments for NASH.
- Study type
- Narrative review
- Who was studied
- United States population
- What was measured
- Metabolic syndrome prevalence, associated diseases, and NASH treatments
THE PAPER
Epidemiology of the metabolic syndrome in the USA.
McCullough AJ. J Dig Dis, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.